000			01986 a2200517 4500
005			20250517020557.0
264		0	_c20150916
008			201509s 0 0 eng d
022			_a2092-6413
024	7		_a10.1038/emm.2014.127 _2doi
040			_aNLM _beng _cNLM
100	1		_aYi, Yong Weon
245	0	0	_aβ-TrCP1 degradation is a novel action mechanism of PI3K/mTOR inhibitors in triple-negative breast cancer cells. _h[electronic resource]
260			_bExperimental & molecular medicine _cFeb 2015
300			_ae143 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Proliferation
650	0	4	_aCell Survival _xdrug effects
650	0	4	_aCyclin E _xgenetics
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aFemale
650	0	4	_aFurans _xpharmacology
650	0	4	_aGene Knockdown Techniques
650	0	4	_aHumans
650	0	4	_aMechanistic Target of Rapamycin Complex 2
650	0	4	_aModels, Biological
650	0	4	_aMultiprotein Complexes _xantagonists & inhibitors
650	0	4	_aPhosphoinositide-3 Kinase Inhibitors
650	0	4	_aPhosphorylation _xdrug effects
650	0	4	_aProtein Kinase Inhibitors _xpharmacology
650	0	4	_aProteolysis _xdrug effects
650	0	4	_aProto-Oncogene Proteins c-myc _xgenetics
650	0	4	_aPyridines _xpharmacology
650	0	4	_aPyrimidines _xpharmacology
650	0	4	_aTOR Serine-Threonine Kinases _xantagonists & inhibitors
650	0	4	_aTriple Negative Breast Neoplasms _xgenetics
650	0	4	_abeta-Transducin Repeat-Containing Proteins _xgenetics
700	1		_aKang, Hyo Jin
700	1		_aBae, Edward Jeong
700	1		_aOh, Seunghoon
700	1		_aSeong, Yeon-Sun
700	1		_aBae, Insoo
773	0		_tExperimental & molecular medicine _gvol. 47 _gp. e143
856	4	0	_uhttps://doi.org/10.1038/emm.2014.127 _zAvailable from publisher's website
999			_c24659830 _d24659830